ATE255892T1 - Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa - Google Patents
Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosaInfo
- Publication number
- ATE255892T1 ATE255892T1 AT00905841T AT00905841T ATE255892T1 AT E255892 T1 ATE255892 T1 AT E255892T1 AT 00905841 T AT00905841 T AT 00905841T AT 00905841 T AT00905841 T AT 00905841T AT E255892 T1 ATE255892 T1 AT E255892T1
- Authority
- AT
- Austria
- Prior art keywords
- bulimia nervosa
- anticonvulsive
- derivatives
- treat bulimia
- treat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11805799P | 1999-02-01 | 1999-02-01 | |
| PCT/US2000/002334 WO2000044374A1 (en) | 1999-02-01 | 2000-01-31 | Use of anticonvulsant derivatives for treating bulimia nervosa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE255892T1 true ATE255892T1 (de) | 2003-12-15 |
Family
ID=22376270
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00905841T ATE255892T1 (de) | 1999-02-01 | 2000-01-31 | Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1148874B1 (de) |
| JP (1) | JP2002535363A (de) |
| KR (1) | KR100664618B1 (de) |
| CN (1) | CN1196482C (de) |
| AR (1) | AR029331A1 (de) |
| AT (1) | ATE255892T1 (de) |
| AU (1) | AU764703B2 (de) |
| BR (1) | BR0007897A (de) |
| CA (1) | CA2360677C (de) |
| CZ (1) | CZ295594B6 (de) |
| DE (1) | DE60007078T2 (de) |
| DK (1) | DK1148874T3 (de) |
| ES (1) | ES2211507T3 (de) |
| HU (1) | HUP0105420A3 (de) |
| IL (1) | IL144407A0 (de) |
| MX (1) | MXPA01007758A (de) |
| NO (1) | NO20013725D0 (de) |
| NZ (1) | NZ513114A (de) |
| PT (1) | PT1148874E (de) |
| TR (1) | TR200102205T2 (de) |
| TW (1) | TW565446B (de) |
| WO (1) | WO2000044374A1 (de) |
| ZA (1) | ZA200107212B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| AU779248B2 (en) | 1999-02-24 | 2005-01-13 | University Of Cincinnati, The | Use of sulfamate derivatives for treating impulse control disorders |
| AU2002227052A1 (en) | 2000-11-30 | 2002-06-11 | University Of Florida | Treatments for neurogenetic disorders, impulse control disorders, and wound healing |
| US6462084B1 (en) * | 2001-05-14 | 2002-10-08 | Brookhaven Science Associates, Llc | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| IT1248588B (it) * | 1991-06-28 | 1995-01-19 | Gaetano Crepaldi | Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari. |
-
2000
- 2000-01-31 IL IL14440700A patent/IL144407A0/xx unknown
- 2000-01-31 CZ CZ20012764A patent/CZ295594B6/cs not_active IP Right Cessation
- 2000-01-31 AU AU27462/00A patent/AU764703B2/en not_active Ceased
- 2000-01-31 TR TR2001/02205T patent/TR200102205T2/xx unknown
- 2000-01-31 CA CA002360677A patent/CA2360677C/en not_active Expired - Fee Related
- 2000-01-31 ES ES00905841T patent/ES2211507T3/es not_active Expired - Lifetime
- 2000-01-31 BR BR0007897-2A patent/BR0007897A/pt not_active Application Discontinuation
- 2000-01-31 PT PT00905841T patent/PT1148874E/pt unknown
- 2000-01-31 MX MXPA01007758A patent/MXPA01007758A/es active IP Right Grant
- 2000-01-31 KR KR1020017009311A patent/KR100664618B1/ko not_active IP Right Cessation
- 2000-01-31 NZ NZ513114A patent/NZ513114A/en unknown
- 2000-01-31 EP EP00905841A patent/EP1148874B1/de not_active Expired - Lifetime
- 2000-01-31 DK DK00905841T patent/DK1148874T3/da active
- 2000-01-31 AT AT00905841T patent/ATE255892T1/de not_active IP Right Cessation
- 2000-01-31 DE DE60007078T patent/DE60007078T2/de not_active Expired - Fee Related
- 2000-01-31 JP JP2000595677A patent/JP2002535363A/ja not_active Withdrawn
- 2000-01-31 CN CNB00803320XA patent/CN1196482C/zh not_active Expired - Fee Related
- 2000-01-31 WO PCT/US2000/002334 patent/WO2000044374A1/en active IP Right Grant
- 2000-01-31 AR ARP000100410A patent/AR029331A1/es not_active Application Discontinuation
- 2000-01-31 HU HU0105420A patent/HUP0105420A3/hu unknown
- 2000-03-09 TW TW089101669A patent/TW565446B/zh not_active IP Right Cessation
-
2001
- 2001-07-30 NO NO20013725A patent/NO20013725D0/no not_active Application Discontinuation
- 2001-08-30 ZA ZA200107212A patent/ZA200107212B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2360677A1 (en) | 2000-08-03 |
| CA2360677C (en) | 2005-07-05 |
| KR20010101665A (ko) | 2001-11-14 |
| ES2211507T3 (es) | 2004-07-16 |
| DE60007078T2 (de) | 2004-12-16 |
| KR100664618B1 (ko) | 2007-01-04 |
| IL144407A0 (en) | 2002-05-23 |
| HUP0105420A2 (hu) | 2002-05-29 |
| PT1148874E (pt) | 2004-04-30 |
| JP2002535363A (ja) | 2002-10-22 |
| CN1338931A (zh) | 2002-03-06 |
| NO20013725L (no) | 2001-07-30 |
| MXPA01007758A (es) | 2003-06-24 |
| BR0007897A (pt) | 2001-10-30 |
| NZ513114A (en) | 2003-10-31 |
| NO20013725D0 (no) | 2001-07-30 |
| WO2000044374A1 (en) | 2000-08-03 |
| AU2746200A (en) | 2000-08-18 |
| TW565446B (en) | 2003-12-11 |
| AU764703B2 (en) | 2003-08-28 |
| ZA200107212B (en) | 2002-12-02 |
| AR029331A1 (es) | 2003-06-25 |
| DE60007078D1 (de) | 2004-01-22 |
| DK1148874T3 (da) | 2004-03-29 |
| CZ295594B6 (cs) | 2005-08-17 |
| EP1148874B1 (de) | 2003-12-10 |
| CN1196482C (zh) | 2005-04-13 |
| EP1148874A1 (de) | 2001-10-31 |
| HUP0105420A3 (en) | 2003-03-28 |
| TR200102205T2 (tr) | 2002-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
| ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE338552T1 (de) | Verwendungen von et743 zur behandlung von krebs | |
| ATE339955T1 (de) | Verwendung von escitalopram zur behandlung von generalisierten angstzuständen | |
| DE60015516D1 (de) | Verwendung von makroliden zur behandlung von trockenen augen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE218862T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
| ATE410181T1 (de) | Verwendung von intereferon gamma zur behandlung von herzhypertrophie | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| ATE326969T1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
| ATE255892T1 (de) | Verwendung von antikonvulsiven derivaten zur behandlung von bulimia nervosa | |
| ATE289196T1 (de) | Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen | |
| ATE270102T1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| ATE209891T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| DE60120990D1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
| DE60103503D1 (de) | Verwendung von fsh zur behandlung von infertilität | |
| ATE433323T1 (de) | Verwendung von erythropoietin zur behandlung von primärer hämochromatosen | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| ATE226440T1 (de) | Zusammensetzung zur behandlung von psoriasis | |
| ATE302023T1 (de) | Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen | |
| DE60012836D1 (de) | Verwendung von Simethicone zur Behandlung der ulzerativen Kolitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1148874 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |